quinoxalines has been researched along with Carcinoma, Epidermoid in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amaral, MEA; Bogo, MR; Campos, MM; Filippi-Chiela, EC; Kist, LW; Mascarello, A; Mielcke, TR; Muradás, TC; Neuenfeldt, PD; Nunes, RJ | 1 |
| Ahmed, O; Cohen, EE; Kuo, WL; Lingen, MW; Liu, J; Macleod, KF; Nagilla, M; Sharifi, MN | 1 |
| Brunner, M; Enzenhofer, E; Haymerle, G; Heiduschka, G; Kadletz, L; Kotowski, U; Stanisz, I; Thurnher, D | 1 |
| Lubet, RA; Miller, MS; Pan, J; Szabo, E; Wang, Y; Xiong, D; You, M; Zhang, Q | 1 |
| Abnet, CC; Cross, AJ; Freedman, ND; Hollenbeck, AR; Ren, J; Schatzkin, A; Sinha, R; Ward, MH | 1 |
| Lagergren, J; Nyrén, O; Steineck, G; Terry, PD; Wolk, A | 1 |
| Hori, H; Kinashi, Y; Masunaga, S; Nagasawa, H; Nagata, K; Ohnishi, K; Ohnishi, T; Ono, K; Suzuki, M; Takahashi, A; Uto, Y | 1 |
| Hori, H; Kinashi, Y; Masunaga, S; Nagasawa, H; Nagata, K; Ono, K; Suzuki, M; Uto, Y | 1 |
| Gotoh, K; Hori, H; Kinashi, Y; Maruhashi, A; Masunaga, S; Nagasawa, H; Nagata, K; Ono, K; Sakurai, Y; Suzuki, M; Uto, Y | 1 |
| Hori, H; Kinashi, Y; Maruhashi, A; Masunaga, S; Nagasawa, H; Nagata, K; Ono, K; Sakurai, Y; Suzuki, M; Uto, Y | 1 |
| Alavanja, MC; Brownson, RC; Curtin, J; Kulldorff, M; Sinha, R; Swanson, CA | 1 |
| Cardesa, A; Dasenbrock, C; Fernandez, PL; Mohr, U; Palacín, A; Pera, M; Tillman, T | 1 |
| Tucker, MJ | 1 |
| Esumi, H; Kudo, M; Ogura, T; Sugimura, T | 1 |
| Blessing, JA; Malfetano, J; Muss, HB | 1 |
| Hasegawa, H; Kato, T; Ohgaki, H; Sato, S; Suenaga, M; Sugimura, T; Takayama, S | 1 |
| Artico, M; Chimenti, F; Dolfini, E; Giuliano, R; Morasca, L; Vomero, S | 2 |
18 other study(ies) available for quinoxalines and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Mechanisms underlying the antiproliferative effects of a series of quinoxaline-derived chalcones.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Chalcones; Class Ib Phosphatidylinositol 3-Kinase; Gene Expression Regulation, Neoplastic; Humans; Molecular Structure; Mouth Neoplasms; Neoplasm Proteins; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Rats; Structure-Activity Relationship; Thiazolidinediones | 2017 |
p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Autophagy; Autophagy-Related Protein 7; Carcinoma, Squamous Cell; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Drug Resistance, Neoplasm; Gene Expression; Heterocyclic Compounds, 3-Ring; Humans; Mouth Neoplasms; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinoxalines; Sequestosome-1 Protein; Sulfonamides; Tissue Array Analysis; Ubiquitin-Activating Enzymes | 2014 |
Assessment of caroverine as a potential chemotherapeutical agent in HNSCC cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cetuximab; Cisplatin; Dose-Response Relationship, Drug; Fluorouracil; Head and Neck Neoplasms; Immunohistochemistry; Mice; Quinoxalines | 2015 |
Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents.
Topics: Animals; Biomarkers, Tumor; Bronchi; Carcinoma, Squamous Cell; Chemokines, CXC; Chemoprevention; Disease Models, Animal; Gene Expression Profiling; Lung Neoplasms; Mice; Pioglitazone; Precancerous Conditions; Quinoxalines; Sulfonamides; Thiazolidinediones; Transcriptome | 2017 |
Meat consumption and risk of esophageal and gastric cancer in a large prospective study.
Topics: Adenocarcinoma; Aged; Carcinogens; Carcinoma, Squamous Cell; Cardia; Esophageal Neoplasms; Feeding Behavior; Female; Follow-Up Studies; Humans; Iron; Male; Meat; Middle Aged; Mutagens; Odds Ratio; Prospective Studies; Quinoxalines; Risk Factors; Stomach Neoplasms; Surveys and Questionnaires; United States | 2011 |
Dietary intake of heterocyclic amines and cancers of the esophagus and gastric cardia.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Cardia; Case-Control Studies; Diet; Esophageal Neoplasms; Feeding Behavior; Female; Heterocyclic Compounds; Hot Temperature; Humans; Imidazoles; Male; Meat; Quinoxalines; Retrospective Studies; Risk Factors; Stomach Neoplasms; Surveys and Questionnaires | 2003 |
Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Cyclic N-Oxides; Gamma Rays; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Micronucleus Tests; Mutation; Organophosphorus Compounds; Quinoxalines; Radiotherapy; Tirapazamine; Triazines; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2005 |
The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclic N-Oxides; Female; Fluorescent Antibody Technique; Hyperthermia, Induced; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasm Transplantation; Neoplasms; Quinoxalines; Tirapazamine; Triazines | 2005 |
Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
Topics: Animals; Borohydrides; Boron; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Fluorescent Antibody Technique, Indirect; Isotopes; Mice; Molecular Structure; Nitriles; Nitroimidazoles; Quinoxalines; Sulfhydryl Compounds; Tissue Distribution | 2006 |
The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
Topics: Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Cell Proliferation; Cell Survival; Combined Modality Therapy; Cyclic N-Oxides; Female; Fluorescent Antibody Technique; Hyperthermia, Induced; Hypoxia; Mice; Mice, Inbred C3H; Micronucleus Tests; Quinoxalines; Quinuclidines; Sulfhydryl Compounds; Time Factors; Tissue Distribution; Tumor Cells, Cultured | 2006 |
Dietary heterocyclic amines and the risk of lung cancer among Missouri women.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Case-Control Studies; Diet; Female; Heterocyclic Compounds; Hot Temperature; Humans; Imidazoles; Lung Neoplasms; Middle Aged; Missouri; Multivariate Analysis; Quinoxalines; Risk Factors; Smoking | 2000 |
Expression of cyclin D1 and p53 and its correlation with proliferative activity in the spectrum of esophageal carcinomas induced after duodenal content reflux and 2,6-dimethylnitrosomorpholine administration in rats.
Topics: Adenocarcinoma; Animals; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cell Division; Cyclin D1; Duodenogastric Reflux; Esophageal Neoplasms; Esophagectomy; Female; Immunoenzyme Techniques; Jejunostomy; Ki-67 Antigen; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53 | 2001 |
Carcinogenic action of quinoxaline 1,4-dioxide in rats.
Topics: Adenocarcinoma; Animals; Carcinogens; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Female; Fibrosarcoma; Hyperplasia; Kidney Neoplasms; Liver Neoplasms; Male; Neoplasms, Experimental; Neuroectodermal Tumors, Primitive, Peripheral; Nose Neoplasms; Precancerous Conditions; Quinoxalines; Rats; Sex Factors | 1975 |
Mutational activation of c-Ha-ras gene in squamous cell carcinomas of rat Zymbal gland induced by carcinogenic heterocyclic amines.
Topics: Animals; Carcinoma, Squamous Cell; Codon; Ear Neoplasms; Ear, External; Gene Expression Regulation, Neoplastic; Genes, ras; Male; Mutagens; Mutation; Quinolines; Quinoxalines; Rats; Rats, Inbred F344; Sebaceous Gland Neoplasms | 1991 |
Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Echinomycin; Female; Humans; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Recurrence, Local; Quinoxalines; Uterine Cervical Neoplasms | 1990 |
Carcinogenicities in mice and rats of IQ, MeIQ, and MeIQx.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinoma; Carcinoma, Squamous Cell; Female; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Quinolines; Quinoxalines; Rats; Rats, Inbred F344; Stomach Neoplasms | 1985 |
[Research on antineoplastic substances. LI. Derivatives of benzo(f)-pyrrolo-(1,2-a)-quinoxaline and naphtho-(2,1-e)-pyrrolo-(2,1-c)-as-triazine: synthesis and cytostatic and cytotoxic activity].
Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cell Line; Cells, Cultured; Culture Media; Humans; Mouth Neoplasms; Nasopharyngeal Neoplasms; Pyrroles; Quinoxalines; Structure-Activity Relationship; Triazines | 1973 |
[Research on substances with antineoplastic activity. LV. Synthesis and cytotoxic and cytostatic effect of heterocyclic azotate compounds related to the 6-aminochrysene].
Topics: Amines; Antineoplastic Agents; Aza Compounds; Carcinoma, Squamous Cell; Culture Media; Humans; In Vitro Techniques; Naphthalenes; Nasopharyngeal Neoplasms; Phenanthrenes; Phenanthridines; Quinolines; Quinoxalines; Schiff Bases | 1974 |